Need help finding what you are looking for?
Contact Us
PUBLISHER: GlobalData | PRODUCT CODE: 1511545
PUBLISHER: GlobalData | PRODUCT CODE: 1511545
Renal Denervation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
PUBLISHED:
PAGES: 104 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
GlobalData's Medical Devices sector report, "Renal Denervation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Renal Denervation Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Renal denervation, also known as renal sympathetic denervation (RSD), is a minimally invasive, catheter-based endovascular procedure that utilizes radiofrequency energy or ultrasound energy to ablate nerves in the walls of the renal artery, causing a reduction in the nerve activity which ultimately reduces the blood pressure in patients with resistant hypertension.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Renal Denervation Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Renal Denervation Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Renal Denervation Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Product Code: GDME1761EPD
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 Renal Denervation Catheters Overview
3 Products under Development
- 3.1 Renal Denervation Catheters - Pipeline Products by Stage of Development
- 3.2 Renal Denervation Catheters - Pipeline Products by Segment
- 3.3 Renal Denervation Catheters - Pipeline Products by Territory
- 3.4 Renal Denervation Catheters - Pipeline Products by Regulatory Path
- 3.5 Renal Denervation Catheters - Pipeline Products by Estimated Approval Date
- 3.6 Renal Denervation Catheters - Ongoing Clinical Trials
4 Renal Denervation Catheters - Pipeline Products under Development by Companies
- 4.1 Renal Denervation Catheters Companies - Pipeline Products by Stage of Development
- 4.2 Renal Denervation Catheters - Pipeline Products by Stage of Development
5 Renal Denervation Catheters Companies and Product Overview
- 5.1 Abbott Vascular Inc Company Overview
- 5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.2 Ablative Solutions Inc Company Overview
- 5.2.1 Ablative Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.3 Brattea Company Overview
- 5.3.1 Brattea Pipeline Products & Ongoing Clinical Trials Overview
- 5.4 CryoMedix, LLC. Company Overview
- 5.4.1 CryoMedix, LLC. Pipeline Products & Ongoing Clinical Trials Overview
- 5.5 Handok-Kalos Medical Company Overview
- 5.5.1 Handok-Kalos Medical Pipeline Products & Ongoing Clinical Trials Overview
- 5.6 Johns Hopkins University Company Overview
- 5.6.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
- 5.7 Kona Medical Inc Company Overview
- 5.7.1 Kona Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.8 Lepu Medical Technology (Beijing) Co Ltd Company Overview
- 5.8.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.9 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
- 5.9.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.10 Mayo Clinic Company Overview
- 5.10.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview
- 5.11 Medtronic Plc Company Overview
- 5.11.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
- 5.12 MicroPort Scientific Corp Company Overview
- 5.12.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
- 5.13 Northwind Medical Inc Company Overview
- 5.13.1 Northwind Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.14 Rainmed Medical Ltd Company Overview
- 5.14.1 Rainmed Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.15 ReCor Medical Inc Company Overview
- 5.15.1 ReCor Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.16 Renal Dynamics, LLC Company Overview
- 5.16.1 Renal Dynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview
- 5.17 Renaly Ltd Company Overview
- 5.17.1 Renaly Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.18 Shanghai AngioCare Medical Technology Co Ltd Company Overview
- 5.18.1 Shanghai AngioCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.19 Shanghai Golden Leaf Medtech Co Ltd Company Overview
- 5.19.1 Shanghai Golden Leaf Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.20 SoniVie Ltd. Company Overview
- 5.20.1 SoniVie Ltd. Pipeline Products & Ongoing Clinical Trials Overview
- 5.21 Sound Interventions, Inc. Company Overview
- 5.21.1 Sound Interventions, Inc. Pipeline Products & Ongoing Clinical Trials Overview
- 5.22 St. Jude Medical LLC Company Overview
- 5.22.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
- 5.23 Suzhou Xinmai Medical Equipment Co Ltd Company Overview
- 5.23.1 Suzhou Xinmai Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.24 Symple Surgical Inc Company Overview
- 5.24.1 Symple Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.25 Tel Aviv University Company Overview
- 5.25.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
- 5.26 Terumo Interventional Systems Company Overview
- 5.26.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
- 5.27 University of Sydney Company Overview
- 5.27.1 University of Sydney Pipeline Products & Ongoing Clinical Trials Overview
- 5.28 Venus Medtech Hangzhou Inc Company Overview
- 5.28.1 Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.29 Verve Medical, Inc. Company Overview
- 5.29.1 Verve Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
6 Renal Denervation Catheters- Recent Developments
7 Appendix
- 7.1 Methodology
- 7.2 About GlobalData
- 7.3 Contact Us
- 7.4 Disclaimer
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.